Enfermedades Infecciosas
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Abad-Fernández M, Vallejo A, Hernández-Novoa B, Díaz L, Gutiérrez C, Madrid N, Muñoz MA, Moreno S.
Correlation Between Different Methods to Measure Microbial Translocation and Its Association With Immune Activation in Long-Term Suppressed HIV-1-Infected Individuals
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 64(2): 149-153. Nº de citas: 38
-
Cervero M, Agud JL, Torres R, García-Lacalle C, Alcázar V, Jusdado JJ, Moreno S.
Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy
HIV MEDICINE . 14(9): 556-562. Nº de citas: 18
-
Horcajada JP, Shaw E, Padilla B, Pintado V, Calbo E, Benito N, Gamallo R, Gozalo M, Rodríguez-Baño J.
Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . 19(10): 962-968. Nº de citas: 81
-
Morosini MI, Quereda C, Gil H, Anda P, Núñez-Murga M, Cantón R, López-Vélez R.
Melioidosis in Traveler from Africa to Spain
EMERGING INFECTIOUS DISEASES . 19(10): 1656-1659. Nº de citas: 21
-
Norman FF, López-Vélez R.
Chagas Disease and Breast-feeding
EMERGING INFECTIOUS DISEASES . 19(10): 1561-1566. Nº de citas: 27
-
Cisneros JM, Cobo J, San Juan R, Montejo M, Fariñas MC.
Education on antibiotic use. Education systems and activities that work.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 31 Suppl 4: 31-37.
-
González C, Torres M, Benito A, Del Romero J, Rodríguez C, Fontillón M, Trastoy M, Viciana P, Del Amo J, Ortiz M, Hernández-Novoa B.
Anal squamous intraepithelial lesions are frequent among young HIV-infected men who have sex with men followed up at the Spanish AIDS Research Network Cohort (CoRIS-HPV)
INTERNATIONAL JOURNAL OF CANCER . 133(5): 1164-1172. Nº de citas: 19
-
Anta L, Blanco JL, Llibre JM, García F, Pérez-Elías MJ, Aguilera A, Pérez-Romero P, Caballero E, Vidal C, Cañizares A, Gutiérrez F, Dalmau D, Iribarren JA, Soriano V, de Mendoza C.
Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes
The Journal of antimicrobial chemotherapy . 68(9): 1994-2002. Nº de citas: 9
-
Mocroft A, Lundgren JD, Sabin ML, Monforte Ad, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S, Fätkenheuer G, Furrer H, Johnson AM, Lazanas MK, Leport C, Moreno S, Obel N, Post FA, Reekie J, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Lozano I, Torti C, Warszawski J, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Kirk O.
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
PLOS MEDICINE . 10(9): . Nº de citas: 228
-
Castronuovo D, Cacopardo B, Pinzone MR, Di Rosa M, Martellotta F, Schioppa O, Moreno S, Nunnari G.
Bone disease in the setting of HIV infection: update and review of the literature
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES . 17(18): 2413-2419. Nº de citas: 34
-
Gutiérrez C, Hernández-Novoa B, Vallejo A, Serrano-Villar S, Abad-Fernández M, Madrid N, Díaz L, Moreno A, Dronda F, Zamora J, Muñoz-Fernández MA, Moreno S.
Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment: results of two clinical trials
AIDS . 27(13): 2081-2088. Nº de citas: 13
-
Hernando V, Alejos B, Monge S, Berenguer J, Anta L, Vinuesa D, Palacios R, Muga R, Moreno S, Jarrin I.
All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010
BMC INFECTIOUS DISEASES . 13: 382-382. Nº de citas: 18
-
Serrano-Villar S, Quereda C, Moreno A, Pérez-Elías MJ, Casado JL, Royuela A, Dronda F, Navas E, Hermida JM, Moreno S.
Neutropenia During Therapy With Peginterferon and Ribavirin in HIV-Infected Subjects With Chronic Hepatitis C and the Risk of Infections
CLINICAL INFECTIOUS DISEASES . 57(3): 458-464. Nº de citas: 3
-
Savini H, Gautret P, Gaudart J, Field V, Castelli F, López-Vélez R, Lim PL, Shaw M, von Sonnenburg F, Loutan L, Simon F.
Travel associated Diseases, Indian Ocean Islands, 1997-2010
EMERGING INFECTIOUS DISEASES . 19(8): 1297-1301. Nº de citas: 17
-
Holguín A, Norman F, Martín L, Mateos ML, Chacón J, López-Vélez R, Pérez-Molina JA.
Dried blood as an alternative to plasma or serum for Trypanosoma cruzi IgG detection in screening programs.
CLINICAL AND VACCINE IMMUNOLOGY . 20(8): 1197-1202. Nº de citas: 17
-
Pérez-Molina JA, Sojo-Dorado J, Norman F, Monge-Maillo B, Díaz-Menéndez M, Albajar-Viñas P, López-Vélez R.
Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment
ACTA TROPICA . 127(2): 101-104. Nº de citas: 28
-
Wikman P, Safont P, Del Palacio M, Moreno A, Moreno S, Casado JL.
The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients
NEPHROLOGY DIALYSIS TRANSPLANTATION . 28(8): 2073-2081. Nº de citas: 17
-
Stellbrink HJ, Reynes J, Lazzarin A, Voronin E, Pulido F, Felizarta F, Almond S, St Clair M, Flack N, Min S, SPRING-1 Team.
Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study.
AIDS . 27(11): 1771-1778. Nº de citas: 105